Home
About
Overview
Sharing Data
ORCID
Help
History (3)
beta Karyopherins
Exon skipping therapy for Duchenne muscular dystrophy.
Noncanonical cytoplasmic poly(A) polymerases regulate RNA levels, alternative RNA processing, and synaptic plasticity but not hippocampal-dependent behaviours.
See All 3 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Exon skipping therapy for Duchenne muscular dystrophy.
Kole R, Krieg AM. Exon skipping therapy for Duchenne muscular dystrophy. Adv Drug Deliv Rev. 2015 Jun 29; 87:104-7.
View in:
PubMed
subject areas
Animals
Dystrophin
Exons
Humans
Morpholinos
Muscular Dystrophy, Duchenne
Mutation
Oligonucleotides
Randomized Controlled Trials as Topic
RNA Splicing
authors with profiles
Arthur M Krieg MD